Outcomes of Magnetic Sphincter Augmentation - A Community Hospital Perspective

Outcomes of Magnetic Sphincter Augmentation - A Community Hospital Perspective

Abstract Background Magnetic sphincter augmentation (MSA) is FDA approved for the surgical treatment of GERD. While multiple reports from academic settings exist, we report the early experience from two community-based health systems. Methods The first 102 post-trial cases of MSA were reviewed. Outc...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The American journal of surgery 2017-06, Vol.213 (6), p.1019-1023
Hauptverfasser: Czosnyka, Nicholas M., MD, Buckley, F. Paul, MD FACS, Doggett, Stephanie L., MS PA-C, Vassaur, Hannah, MS PA-C, Connolly, Erin E., APNP, Borgert, Andrew J., PhD, Kallies, Kara J., MS, Kothari, Shanu N., MD FACS
Format: Artikel
Sprache:eng
Schlagworte:
Acids
Adult
Aged
Aged, 80 and over
Antireflux surgery
Augmentation
Clinical trials
Communities
Dementia
Diet
Drugs
Dysphagia
Early experience
Esophageal Sphincter, Lower
Esophagus
Feasibility studies
Female
Gastroesophageal reflux
Gastroesophageal Reflux - surgery
Gastrointestinal surgery
Health Status
Heart attacks
Hernias
Hospitals
Hospitals, Community
Humans
Laparoscopy
Lower esophageal sphincter
Magnetic sphincter augmentation
Magnets
Male
Middle Aged
Patient Satisfaction
Postoperative outcomes
Prostheses and Implants
Quality of Life
Reproducibility
Retrospective Studies
Reviews
Sphincter
Surgeons
Surgery
Treatment Outcome
Young Adult
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Abstract Background Magnetic sphincter augmentation (MSA) is FDA approved for the surgical treatment of GERD. While multiple reports from academic settings exist, we report the early experience from two community-based health systems. Methods The first 102 post-trial cases of MSA were reviewed. Outcomes were compared to those in the initial clinical trial. Results Mean follow-up duration was 7.6 months. GERD medication use decreased from 98% preoperative to 8% postoperative ( P
ISSN:0002-9610
1879-1883
DOI:10.1016/j.amjsurg.2016.09.044